These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8169177)

  • 21. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
    Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
    Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
    Tolin DF; Maltby N; Diefenbach GJ; Hannan SE; Worhunsky P
    J Clin Psychiatry; 2004 Jul; 65(7):922-31. PubMed ID: 15291681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
    March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
    Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.
    Sousa MB; Isolan LR; Oliveira RR; Manfro GG; Cordioli AV
    J Clin Psychiatry; 2006 Jul; 67(7):1133-9. PubMed ID: 16889458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
    Aspvall K; Andersson E; Melin K; Norlin L; Eriksson V; Vigerland S; Jolstedt M; Silverberg-Mörse M; Wallin L; Sampaio F; Feldman I; Bottai M; Lenhard F; Mataix-Cols D; Serlachius E
    JAMA; 2021 May; 325(18):1863-1873. PubMed ID: 33974020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive disorders.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 2013 Feb; 22 Suppl 1():S23-8. PubMed ID: 23208425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of obsessive-compulsive disorder: personal follow-up of a 10-year material from an outpatient county clinic.
    Olsen T; Mais AH; Bilet T; Martinsen EW
    Nord J Psychiatry; 2008; 62(1):39-45. PubMed ID: 18389424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches.
    Storch EA; Geffken GR; Merlo LJ; Mann G; Duke D; Munson M; Adkins J; Grabill KM; Murphy TK; Goodman WK
    J Am Acad Child Adolesc Psychiatry; 2007 Apr; 46(4):469-478. PubMed ID: 17420681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.
    Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB
    Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.
    Tenneij NH; van Megen HJ; Denys DA; Westenberg HG
    J Clin Psychiatry; 2005 Sep; 66(9):1169-75. PubMed ID: 16187776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
    Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS
    JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination treatment in children and adolescent with obsessive compulsive disorders].
    Wewetzer C; Walitza S
    MMW Fortschr Med; 2005 Dec; 147(48):36, 38-40. PubMed ID: 16389860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone.
    Biondi M; Picardi A
    Psychother Psychosom; 2005; 74(2):123-8. PubMed ID: 15741763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood Obsessive-Compulsive Disorder.
    Schuyler M; Geller DA
    Psychiatr Clin North Am; 2023 Mar; 46(1):89-106. PubMed ID: 36740357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
    Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial.
    Belotto-Silva C; Diniz JB; Malavazzi DM; Valério C; Fossaluza V; Borcato S; Seixas AA; Morelli D; Miguel EC; Shavitt RG
    J Anxiety Disord; 2012 Jan; 26(1):25-31. PubMed ID: 21907540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Ginsburg GS; Kingery JN; Drake KL; Grados MA
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
    Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
    Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.